一种新的药物,即2-HDP,通过保护糖尿病大鼠和人类视网膜细胞,在预防与糖尿病有关的视力丧失方面显示了希望。 A new drug, 2-HDP, shows promise in preventing diabetes-related vision loss by protecting retinal cells in diabetic rats and humans.

一种名为2-HDP的新药在预防糖尿病患者的视力丧失方面很有希望, A new drug called 2-HDP shows promise in preventing vision loss in people with diabetes, according to a study led by Queen’s University Belfast and funded by Diabetes UK. 治疗在糖尿病大鼠体内保护视网膜细胞和血管,减少炎症,并通过消除因高血糖在视网膜中积聚的有害分子来保持视力。 The treatment protected retinal cells and blood vessels in diabetic rats, reduced inflammation, and preserved vision by neutralizing harmful molecules that build up in the retina due to high blood sugar. 研究人员在人类视网膜组织中从糖尿病患者身上检测到同样的有毒分子,这表明这种药物对人体可能有效。 Researchers detected these same toxic molecules in human retinal tissue from people with diabetes, suggesting the drug could be effective in humans. 计算机模拟表明,它可以发展成口服药片。 Computer simulations indicate it may be developed into an oral tablet. 在《Diabetologia》中发表的研究结果突出表明,早期干预有可能阻止不可逆转的损害,为新一代治疗提供希望,为数百万人保留远景。 The findings, published in Diabetologia, highlight the potential for early intervention to stop irreversible damage, offering hope for a new generation of treatments that could preserve vision for millions.